Nkarta NKTX
NASDAQ NKTX
$2.66 +0.19 (+7.69%)
At close: Aug 21, 2026 · 4:00 PM EDT

Nkarta (NKTX) Amortizatization of Intangibles (2020 - 2026)

Nkarta (NKTX) posted quarterly Amortizatization of Intangibles of $753000.0 for Q1 2026, down 51.88% year-over-year from $1.6 million in Q1 2025, and down 11.93% quarter-over-quarter from $855000.0 in Q4 2025.

Nkarta (NKTX) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Nkarta's Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $753000.0 for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles fell 51.88% year-over-year to $753000.0; the TTM figure through Mar 2026 stood at $3.8 million (down 45.46% YoY), while the FY2025 annual figure was $4.6 million, down 33.74% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $753000.0, down from $855000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $2.4 million in Q3 2023, with the low at -$727000.0 in Q1 2022.
  • The 5-year median for Amortizatization of Intangibles is $1.6 million (2025), against an average of $1.3 million.
  • The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles jumped 689.56% in 2023, then slumped 55.79% in 2025.
  • Nkarta's Amortizatization of Intangibles stood at $1.6 million in 2022, then gained by 28.08% to $2.0 million in 2023, then slipped by 4.49% to $1.9 million in 2024, then slumped by 55.79% to $855000.0 in 2025, then fell by 11.93% to $753000.0 in 2026.
  • Business Quant data shows NKTX's Amortizatization of Intangibles at $753000.0 in Q1 2026, $855000.0 in Q4 2025, and $953000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Nkarta 201.14 Mn 201.14 Mn - 464,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 464,000.00
Jun 30, 2026 464,000.00
Mar 31, 2026 753,000.00
Mar 31, 2026 753,000.00
Dec 31, 2025 855,000.00
Dec 31, 2025 855,000.00
Sep 30, 2025 953,000.00
Sep 30, 2025 953,000.00
Jun 30, 2025 1.21 Mn
Jun 30, 2025 1.21 Mn
Mar 31, 2025 1.57 Mn
Mar 31, 2025 1.57 Mn
Dec 31, 2024 1.93 Mn
Dec 31, 2024 1.93 Mn
Sep 30, 2024 1.96 Mn
Sep 30, 2024 1.96 Mn
Jun 30, 2024 1.45 Mn
Jun 30, 2024 1.45 Mn
Mar 31, 2024 1.57 Mn
Mar 31, 2024 1.57 Mn